AstraZeneca sold its stake in rival COVID-19 vaccine maker Moderna for roughly $1 billion over the course of last year as the Anglo-Swedish drugmaker cashed in on the meteoric rise in the U.S. company’s shares. London-listed AstraZeneca recorded…
Astrazeneca has sold its stake in Moderna for more than $1 billion: The Times
